Bicycle Therapeutics (BCYC) Accumulated Depreciation (2018 - 2024)
Bicycle Therapeutics (BCYC) posted Accumulated Depreciation of $16.6 million for Q2 2024, up 11.14% on a QoQ basis from $14.9 million in Q1 2024, and up 59.03% year-over-year from $10.4 million in Q3 2023.
Bicycle Therapeutics (BCYC) Accumulated Depreciation (2018 - 2024) Analysis & Trends
Bicycle Therapeutics' Accumulated Depreciation history runs 7 years deep, the most recent figure standing at $16.6 million for Q2 2024.
- Quarterly Accumulated Depreciation rose 59.03% year-over-year to $16.6 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $16.6 million (up 59.03% YoY) and the FY2023 annual result came in at $13.4 million, up 70.33% from the prior year.
- Accumulated Depreciation was $16.6 million for Q2 2024 at Bicycle Therapeutics, up from $14.9 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $16.6 million in Q2 2024 and bottomed at $2.8 million in Q1 2020.
- A 5-year average of $7.3 million and a median of $5.1 million in 2022 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2022 — Accumulated Depreciation gained 15.09% — and 2023, when it soared 101.58%.
- Bicycle Therapeutics' Accumulated Depreciation stood at $4.0 million in 2020, then grew by 19.05% to $4.8 million in 2021, then jumped by 63.81% to $7.9 million in 2022, then surged by 70.33% to $13.4 million in 2023, then climbed by 23.99% to $16.6 million in 2024.
- Business Quant data shows BCYC's Accumulated Depreciation at $16.6 million in Q2 2024, $14.9 million in Q1 2024, and $13.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 16.61 Mn |
| Mar 31, 2024 | 14.94 Mn |
| Dec 31, 2023 | 13.39 Mn |
| Sep 30, 2023 | 11.40 Mn |
| Jun 30, 2023 | 10.44 Mn |
| Mar 31, 2023 | 8.76 Mn |
| Dec 31, 2022 | 7.86 Mn |
| Sep 30, 2022 | 6.02 Mn |
| Jun 30, 2022 | 5.18 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 4.80 Mn |
| Sep 30, 2021 | 4.73 Mn |
| Jun 30, 2021 | 4.50 Mn |
| Mar 31, 2021 | 4.20 Mn |
| Dec 31, 2020 | 4.03 Mn |
| Sep 30, 2020 | 3.50 Mn |
| Jun 30, 2020 | 3.06 Mn |
| Mar 31, 2020 | 2.82 Mn |
| Dec 31, 2019 | 2.68 Mn |
| Sep 30, 2019 | 2.26 Mn |